ArticleBiologics : targets & therapy2025

Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review.

Giorgio Galoppini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.